Literature DB >> 23130835

Chromatin regulators with tumor suppressor properties and their alterations in human cancers.

Xing-Sheng Shu1, Lili Li, Qian Tao.   

Abstract

Key components of the cell epigenome include DNA CpG methylation profile and chromatin modification patterns. Chromatin regulators act as master controllers of gene transcription in normal cells through regulation of histone modifications and chromatin remodeling. During human cancer pathogenesis, the functions of chromatin regulators are frequently disrupted by genetic mutations and/or epigenetic alterations, causing perturbation of broad or even genome-wide scale gene-expression profiles. Thus, histone-modifying and chromatin-remodeling genes can be taken as critical 'cancer genes'. This review summarizes the current knowledge on chromatin regulators with tumor suppressor properties, as well as their aberrant alterations in human cancers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23130835     DOI: 10.2217/epi.12.50

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  6 in total

1.  Phospho-ΔNp63α/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomas.

Authors:  Edward A Ratovitski
Journal:  Cell Cycle       Date:  2014-01-06       Impact factor: 4.534

Review 2.  Oncogenic Epstein-Barr virus recruits Nm23-H1 to regulate chromatin modifiers.

Authors:  Saurabh Pandey; Erle S Robertson
Journal:  Lab Invest       Date:  2017-10-16       Impact factor: 5.662

3.  Histone Deacetylase 3 Inhibitor Suppresses Hepatitis C Virus Replication by Regulating Apo-A1 and LEAP-1 Expression.

Authors:  Yuan Zhou; Qian Wang; Qi Yang; Jielin Tang; Chonghui Xu; Dongwei Gai; Xinwen Chen; Jizheng Chen
Journal:  Virol Sin       Date:  2018-10-17       Impact factor: 4.327

4.  MBD3 localizes at promoters, gene bodies and enhancers of active genes.

Authors:  Takashi Shimbo; Ying Du; Sara A Grimm; Archana Dhasarathy; Deepak Mav; Ruchir R Shah; Huidong Shi; Paul A Wade
Journal:  PLoS Genet       Date:  2013-12-26       Impact factor: 5.917

5.  TESTIN suppresses tumor growth and invasion via manipulating cell cycle progression in endometrial carcinoma.

Authors:  Zhenpeng Gu; Guofeng Ding; Kuixiang Liang; Hongtao Zhang; Guanghong Guo; Lili Zhang; Jinxiu Cui
Journal:  Med Sci Monit       Date:  2014-06-14

6.  Target sequencing and CRISPR/Cas editing reveal simultaneous loss of UTX and UTY in urothelial bladder cancer.

Authors:  Jinwoo Ahn; Kwang Hyun Kim; Sanghui Park; Young-Ho Ahn; Ha Young Kim; Hana Yoon; Ji Hyun Lee; Duhee Bang; Dong Hyeon Lee
Journal:  Oncotarget       Date:  2016-09-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.